Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reactive immunoblastic proliferations.

B N Nathwani1, R K Brynes

  • 1Department of Pathology, University of Southern California, School of Medicine, Los Angeles 90033.

Seminars in Diagnostic Pathology
|November 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital image analysis agrees with visual estimates of adult bone marrow trephine biopsy cellularity.

International journal of laboratory hematology·2017
Same author

ICSH guidelines for the standardization of bone marrow immunohistochemistry.

International journal of laboratory hematology·2015
Same author

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.

Nature communications·2014
Same author

Aplastic anemia secondary to azathioprine in systemic lupus erythematosus: report of a case with normal thiopurine S-methyltransferase enzyme activity and review of the literature.

Lupus·2013
Same author

Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins.

British journal of cancer·2013
Same author

beta-Catenin expression in thyroid follicular lesions: potential role in nuclear envelope changes in papillary carcinomas.

Endocrine pathology·2005
Same journal

Update on the molecular pathology of the distinctive giant cell, fibro-osseous and bone forming lesions of the jaws.

Seminars in diagnostic pathology·2026
Same journal

Update on the molecular pathology and classification of odontogenic cysts and tumours.

Seminars in diagnostic pathology·2026
Same journal

MDM2 gene amplification in surgical pathology: biology, diagnostic utility, and clinical relevance in the modern era.

Seminars in diagnostic pathology·2026
Same journal

When three negatives equal a positive: Molecular updates of triple-negative breast carcinomas with favorable prognoses.

Seminars in diagnostic pathology·2026
Same journal

Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification.

Seminars in diagnostic pathology·2026
Same journal

Recent advances in genetic predisposition to primary testicular tumors.

Seminars in diagnostic pathology·2026
See all related articles

This report outlines criteria for identifying benign immunoblastic lymphadenitis and differentiating it from malignant conditions. Accurate diagnosis relies on comprehensive histologic assessment, not solely on cell appearance.

Area of Science:

  • Pathology
  • Immunology
  • Oncology

Background:

  • Immunoblastic proliferations are characteristic of various benign conditions.
  • Distinguishing benign from neoplastic immunoblastic proliferations is clinically significant.

Purpose of the Study:

  • To define criteria for recognizing benign immunoblastic lymphadenitis.
  • To differentiate benign immunoblastic proliferations from neoplastic ones.

Main Methods:

  • Histologic evaluation of architectural patterns.
  • Assessment of cellular composition and relationships.
  • Cytologic features of immunoblasts (transformed lymphoid cells).

Main Results:

  • Benign conditions like viral lymphadenitis show immunoblast proliferation.

Related Experiment Videos

  • Distinction from malignancy requires analysis of overall histology, not just cytology.
  • Immunoblasts are medium to large transformed lymphoid cells, B or T cell type.

    • Conclusions:

    • Histologic parameters are crucial for differentiating benign from malignant immunoblastic proliferations.
    • Comprehensive assessment of architecture and cellularity aids diagnosis.
    • Cytologic features alone are insufficient for definitive diagnosis.